Medical News

RSS

New therapy for people suffering from body dysmorphic disorder

A nose job to treat a mental health problem? Teeth whitening to overcome a severe anxiety disorder? These are just two procedures that people with body dysmorphic disorder (BDD) have traditionally turned to in order to deal with body-related concerns.

29 Jun 2010

Astellas presents ASP1941 selective SGLT2 inhibitor Phase 2 study results at 70th ADA

Astellas Pharma Inc. announced that the company presented results from a Japanese Phase 2 study conducted with ASP1941, a selective SGLT2 inhibitor, at the 70th Scientific Sessions of the American Diabetes Association (ADA) on June 26, 2010 (EST). ASP1941 is designed to block the re-absorption of glucose in the kidney and excrete glucose in the urine.

29 Jun 2010

Older adults spend more time watching TV, but find it less enjoyable

We usually scold our children and teenagers for watching too much TV. It turns out that their grandmas and grandpas spend even more of their time watching TV, and it is not good for them either, according to researchers at the Stein Institute for Research on Aging and Rady School of Management at the University of California, San Diego School of Medicine.

29 Jun 2010

Older adults experience more supportive friendships, less conflict with children and siblings

Part of what makes those relationships so golden during the golden years is that people of all ages are more likely to forgive and respect one's elders, according to research from Purdue University.

29 Jun 2010

Quark reports results from QPI-1007 siRNA drug study in rat ocular hypertension model of glaucoma

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.

29 Jun 2010

Maternal alcohol consumption impacts semen concentration in male offspring

Mothers who drink alcohol while they are pregnant may be damaging the fertility of their future sons, according to new research to be presented at the 26th annual meeting of the European Society of Human Reproduction and Embryology in Rome today (Tuesday 29 June).

29 Jun 2010

Millions of cancer survivors are parenting young children, says Wake Forest researcher

In the first ever published estimate of the percentage and number of cancer survivors who live with their minor children, a team led by a Wake Forest University Baptist Medical Center researcher found that millions of cancer survivors are parenting young children, highlighting a group of survivors with very special needs.

29 Jun 2010

Meniscal, cruciate ligament lesions increase risk of knee osteoarthritis

Arthroscopic surgical repair of torn anterior cruciate ligaments (ACL) or meniscal cartilage injuries in the knee does not decrease the chances of developing osteoarthritis, according to a new study published in the online edition and August print issue of the journal Radiology.

29 Jun 2010

Researchers suggest factors that predict pre-Alzheimer's condition

Mild cognitive impairment is often seen as a transition stage between the cognitive decline of normal aging and the more serious problems of Alzheimer's disease. But what leads to mild cognitive impairment?

29 Jun 2010

FDA approves Teva's generic Effexor XR antidepressant

Teva Pharmaceutical Industries Ltd. announced today U.S. Food and Drug Administration (FDA) approval of Venlafaxine HCl ER Capsules, the Company's generic version of Wyeth's antidepressant Effexor XR®. Shipment is expected to commence on July 1, 2010, as per the terms of the 2006 agreement with Wyeth.

29 Jun 2010

Scientists discover new mechanism of H5N1 circulation and transmission in nature

A team of scientists, led by Mauro Delogu, virologist from the Veterinary Faculty of the Bologna University and researchers from the Istituto Superiore di Sanit-, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia and St. Jude Children's Research Hospital (Memphis, Tennessee) have discovered a new way of avian influenza transmission.

29 Jun 2010

Response Biomedical signs subscription agreement for C$8 million private placement

Response Biomedical Corporation announced today the signing of a subscription agreement providing for the sale of C$8 million of its common shares to funds affiliated with OrbiMed Advisors, LLC. The closing of the private placement is subject to receipt of all necessary regulatory approvals, including the approval of the Toronto Stock Exchange and the shareholders of the Company.

29 Jun 2010

International symposium to highlight current and future applications of MR-guided ultrasound

Leading research and clinical experts from around the world are scheduled to speak at the 2nd International Symposium for MR-guided Focused Ultrasound, which will be held October 17 to 20 in the Washington, D.C. area.

From Elekta 29 Jun 2010

AFREZZA provides long-term glucose control in Type 2 diabetics: Study

AFREZZA (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes treatment regimen, provides long-term glucose control comparable to usual insulin therapy but with a significantly reduced incidence of hypoglycemia and less weight gain in patients with Type 2 diabetes, according to a two-year study presented today at the American Diabetes Association's 70th Scientific Sessions.

29 Jun 2010

Researchers use neonatal piglet model to study infant brain development

Events occurring during the development of an infant's brain can leave behind fingerprints. And researchers at the University of Illinois are interested in learning how these fingerprints can predict future behavioral problems such as cognitive deficits, anxiety disorders, depression, and even autism.

29 Jun 2010

Avila's AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis

Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced results of preclinical studies demonstrating that its clinical candidate, AVL-292, potently inhibits B cell receptor signaling, and demonstrates efficacy in a rodent model of rheumatoid arthritis. These new data were presented Saturday, June 26, 2010 at the Federation of Clinical Immunology Societies (FOCIS) 2010 annual meeting in Boston, MA.

29 Jun 2010

Study finds high sugar content in toddler and baby food products

Fifty three percent of food products specifically targeted to babies and toddlers in Canadian grocery stores have an excessive proportion-more than 20 per cent-of calories coming from sugar, according to a new study by University of Calgary professor Charlene Elliott.

29 Jun 2010

Medical News

New therapy for people suffering from body dysmorphic disorder

Astellas presents ASP1941 selective SGLT2 inhibitor Phase 2 study results at 70th ADA

Older adults spend more time watching TV, but find it less enjoyable

Older adults experience more supportive friendships, less conflict with children and siblings

Quark reports results from QPI-1007 siRNA drug study in rat ocular hypertension model of glaucoma

Maternal alcohol consumption impacts semen concentration in male offspring

Millions of cancer survivors are parenting young children, says Wake Forest researcher

Meniscal, cruciate ligament lesions increase risk of knee osteoarthritis

Researchers suggest factors that predict pre-Alzheimer's condition

FDA approves Teva's generic Effexor XR antidepressant

Scientists discover new mechanism of H5N1 circulation and transmission in nature

Response Biomedical signs subscription agreement for C$8 million private placement

International symposium to highlight current and future applications of MR-guided ultrasound

AFREZZA provides long-term glucose control in Type 2 diabetics: Study

Researchers use neonatal piglet model to study infant brain development

Avila's AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis

Study finds high sugar content in toddler and baby food products

Young breast cancer patients more likely to discontinue hormone therapy

New research project to develop reliable and cost-effective virtual autopsies

New equation offers accurate estimation of peak heart rate for women

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Latest News